Stéphane De Maeght
About
In The Last Decade
Stéphane De Maeght
20 papers receiving 343 citations
Peers
Comparison fields: 5 of 67
- Epidemiology 185
- Hepatology 164
- Surgery 82
- Pulmonary and Respiratory Medicine 62
- Radiology, Nuclear Medicine and Imaging 62
Countries citing papers authored by Stéphane De Maeght
This map shows the geographic impact of Stéphane De Maeght's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stéphane De Maeght with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stéphane De Maeght more than expected).
Fields of papers citing papers by Stéphane De Maeght
This network shows the impact of papers produced by Stéphane De Maeght. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stéphane De Maeght. The network helps show where Stéphane De Maeght may publish in the future.
Co-authorship network of co-authors of Stéphane De Maeght
This figure shows the co-authorship network connecting the top 25 collaborators of Stéphane De Maeght. A scholar is included among the top collaborators of Stéphane De Maeght based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stéphane De Maeght. Stéphane De Maeght is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | Update of the Belgian Association for the Study of the Liver guidelines for the treatment of chronic hepatitis C genotype 1 with protease inhibitors. | 2 |
| 3 | IL28B polymorphism and the control of hepatitis C virus infection: ready for clinical use? | 1 |
| 4 | High prevalence of advanced fibrosis in association with the metabolic syndrome in a Belgian prospective cohort of NAFLD patients with elevated ALT. Results of the Belgian NAFLD registry. | 16 |
| 5 | Acute upper gastrointestinal bleeding in cirrhosis: changes and advances over the past two decades. | 6 |
| 6 | 39 | |
| 7 | 6 | |
| 8 | 10 | |
| 9 | A pilot observational survey of hepatitis C in Belgium. | 8 |
| 10 | 46 | |
| 11 | 55 | |
| 12 | Dépistage du carcinome hépatocellulaire dans une cohorte de malades porteurs d'une cirrhose d'origine principalement alcoolique. | 13 |
| 13 | [Screening for hepatocarcinoma in a cohort with cirrhosis mainly of alcoholic origin]. | 11 |
| 14 | Surveillance for hepatocellular carcinoma: compliance and results according to the aetiology of cirrhosis in a cohort of 141 patients. | 16 |
| 15 | [lymphocytic colitis associated with lansoprazole treatment]. | 9 |
| 16 | Thromboembolism in inflammatory bowel disease. | 15 |
| 17 | Hypoxic hepatitis: a difficult diagnosis when the cardiomyopathy remains unrecognized and the course of liver enzymes follows an atypical pattern. A report of two cases. | 5 |
| 18 | Contribution of labeled CO2 to PET images of the liver with [2-11C]thymidine. | 0 |
| 19 | PET study of human cerebral malignancy with [2-11C]thymidine and [18F]FDG. | 2 |
| 20 | 34 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.